Dirk Kieback

1.3k total citations
24 papers, 877 citations indexed

About

Dirk Kieback is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Dirk Kieback has authored 24 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Dirk Kieback's work include Virus-based gene therapy research (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer Research and Treatments (5 papers). Dirk Kieback is often cited by papers focused on Virus-based gene therapy research (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer Research and Treatments (5 papers). Dirk Kieback collaborates with scholars based in Germany, United States and Netherlands. Dirk Kieback's co-authors include J. Wesley Pike, Peter J. Malloy, Bert W. O’Malley, Mark Hughes, Robert A. Kesterson, David Feldman, Xiaowen Tong, Ingo B. Runnebaum, Estuardo Aguilar-Córdova and Annette Hasenburg and has published in prestigious journals such as Science, The Journal of Clinical Endocrinology & Metabolism and FEBS Letters.

In The Last Decade

Dirk Kieback

23 papers receiving 853 citations

Peers

Dirk Kieback

GENET

ONCOL

PFM

EDM

Ulrike Schwarz‐Boeger Germany

Hein F.B.M. Sleddens Netherlands

Serge Garbay France

E. Scott Swenson United States

Phillip Koeffler United States

Kerstin Enquist Sweden

Takesada Mori Japan

Lyle E. Pegg United States

Stephen J. Weber-Hall United Kingdom

Tahereh Kamalati United Kingdom

Ulrike Schwarz‐Boeger Germany

Dirk Kieback

401 ×1.0

215 ×0.6

GENET

172 ×0.8

ONCOL

81 ×0.4

PFM

16 ×0.2

EDM

Citations per year, relative to Dirk Kieback Dirk Kieback (= 1×) peers Ulrike Schwarz‐Boeger

Countries citing papers authored by Dirk Kieback

Since Specialization

Citations

This map shows the geographic impact of Dirk Kieback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Kieback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Kieback more than expected).

Fields of papers citing papers by Dirk Kieback

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Kieback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Kieback. The network helps show where Dirk Kieback may publish in the future.

Co-authorship network of co-authors of Dirk Kieback

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Kieback. A scholar is included among the top collaborators of Dirk Kieback based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Kieback. Dirk Kieback is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Orr, James W., Joseph L. Kelley, Don S. Dizon, et al.. (2008). Society of Gynecologic Oncologists Position Paper: Breast Cancer Care. Gynecologic Oncology. 110(1). 7–12. 2 indexed citations

Stark, Michael, et al.. (2008). Post-cesarean adhesions–are they a unique entity?. The Journal of Maternal-Fetal & Neonatal Medicine. 21(8). 513–516. 16 indexed citations

Janát‐Amsbury, Margit M., James W. Yockman, Matthew L. Anderson, Dirk Kieback, & Sung Wan Kim. (2006). Comparison of ID8 MOSE and VEGF-modified ID8 cell lines in an immunocompetent animal model for human ovarian cancer.. PubMed. 26(4B). 2785–9. 34 indexed citations

Chi, Dennis, Nadeem R. Abu‐Rustum, Yukio Sonoda, et al.. (2005). Papers to Appear in Forthcoming Issues. Gynecologic Oncology. 100(1). 221–221. 1 indexed citations

Romano, Andrea, Patrick Lindsey, Dagmar‐C. Fischer, et al.. (2005). Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer. Gynecologic Oncology. 101(2). 287–295. 39 indexed citations

LoRusso, Patricia, Roy S. Herbst, Danny Rischin, et al.. (2003). Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors.. PubMed. 9(6). 2040–8. 40 indexed citations

Watermann, Dirk, et al.. (2003). Experience with the Advanced Breast Biopsy Instrumentation (ABBI) system.. PubMed. 22(5). 3067–70. 4 indexed citations

Kieback, Dirk, Dagmar‐Christiane Fischer, Dirk G. Engehausen, et al.. (2002). Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer. Cancer Gene Therapy. 9(5). 478–481. 10 indexed citations

You, Zongbing, et al.. (2001). Coxsackievirus–adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression. Cancer Gene Therapy. 8(3). 168–175. 51 indexed citations

10.

Stickeler, Elmar, Suwanit Therasakvichya, Volker Moebus, et al.. (2001). Modulation of soluble CD44 concentrations by hormone and anti-hormone treatment in gynecological tumor cell lines. Oncology Reports. 8(6). 1381–6. 1 indexed citations

11.

Hasenburg, Annette, Augusto Rojas-Martı́nez, Cassandra Nyberg-Hoffman, et al.. (2000). Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer. Cancer Gene Therapy. 7(6). 839–844. 53 indexed citations

12.

Tong, Xiaowen, Andreas Block, Charles F. Contant, et al.. (2000). Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter.. PubMed. 20(5A). 2811–6. 9 indexed citations

13.

Kieback, Dirk, et al.. (1999). MOLECULAR ASPECTS OF OVARIAN CANCER. Hematology/Oncology Clinics of North America. 13(1). 109–133. 9 indexed citations

14.

Tong, Xiaowen, Dirk G. Engehausen, Irina U. Agoulnik, et al.. (1999). Comparison of Long-term Survival of Cytomegalovirus Promoter versus Rous Sarcoma Virus Promoter-Driven Thymidine Kinase Gene Therapy in Nude Mice Bearing Human Ovarian Cancer. Hybridoma. 18(1). 93–97. 8 indexed citations

15.

Hasenburg, Annette, Xiaowen Tong, Augusto Rojas-Martı́nez, et al.. (1999). Thymidine kinase (TK) gene therapy of solid tumors: valacyclovir facilitates outpatient treatment.. PubMed. 19(3B). 2163–5. 11 indexed citations

16.

Kohlberger, Petra, et al.. (1998). Evidence of Androgen Receptor Expression in Lichen Sclerosus: An Immunohistochemical Study. Journal of the Society for Gynecologic Investigation. 5(6). 331–333. 5 indexed citations

17.

Kohlberger, Petra, Dirk Kieback, F Breitenecker, et al.. (1997). Epithelial and Stromal Estrogen and Progesterone Receptor Expression in Endometrial Cancer: True Color Computer-Assisted Image Analysis versus Subjective Scoring. Gynecologic Oncology. 64(3). 404–410. 11 indexed citations

18.

Kohlberger, Petra, Dirk Kieback, Elmar Stickeler, et al.. (1997). Immunohistochemical Detection of CD44 Splice Variant Expression in Premalignant Lesions of the Cervix and Benign Cervical Epithelium. Gynecologic Oncology. 66(2). 227–232. 16 indexed citations

19.

Runnebaum, Ingo B., et al.. (1994). p53 mutant His¹⁷⁵ identified in a newly established fallopian tube carcinoma cell line secreting interleukin 6. FEBS Letters. 353(1). 29–32. 12 indexed citations

20.

Hughes, Mark, Peter J. Malloy, Dirk Kieback, et al.. (1988). Point mutations in the Human Vitamin D Receptor Gene Associated with Hypocalcemic Rickets. Science. 242(4886). 1702–1705. 355 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact